Cargando…

Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine

Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future. Patients with a background of Raynaud's phenomen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manickam, Agaath Hedina, Buture, Alina, Tomkins, Esther, Ruttledge, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365535/ https://www.ncbi.nlm.nih.gov/pubmed/34430000 http://dx.doi.org/10.1002/ccr3.4625

Ejemplares similares

Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17–30 months
por: Troy, Emma, et al.
Publicado: (2023)

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension
por: Lee, Yong Jig, et al.
Publicado: (2018)

Koilonychia secondary to Raynaud's phenomenon: A rare co-occurrence
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Glomus Tumor Presenting as Raynaud's Phenomenon
por: Abdelrahman, M. H., et al.
Publicado: (2012)

Monostotic fibrous dysplasia with Raynaud's phenomenon
por: Kumar, K. V. S. Hari, et al.
Publicado: (2015)

Pacinian hyperplasia presenting with Raynaud’s phenomenon
por: Pickrell, Brent B., et al.
Publicado: (2019)

Mitochondrial genetics and therapeutic overview of Leber's hereditary optic neuropathy
por: Manickam, Agaath Hedina, et al.
Publicado: (2017)

Chemotherapeutic Resistance Genes of Breast Cancer Patients - An Overview
por: Ajith, Anagha Kollamparambil, et al.
Publicado: (2022)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Incontinentia pigmenti with secondary Raynaud's phenomenon: A case report and review of the literature
por: Greven, Margaret A., et al.
Publicado: (2016)

Finger pad tophi in a patient with Raynaud phenomenon
por: Zarbafian, Misha, et al.
Publicado: (2017)

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
por: Güneş, Serkan, et al.
Publicado: (2018)

Innovations in the Assessment of Primary and Secondary Raynaud’s Phenomenon
por: Ruaro, Barbara, et al.
Publicado: (2019)

A serious case of primary Raynaud's phenomenon in an infant
por: Kobayashi, Masaru, et al.
Publicado: (2018)

Secukinumab-induced Raynaud’s phenomenon: first report in the literature
por: Kobak, Senol
Publicado: (2020)

Raynaud Phenomenon of the Nipple: A Clinical Case Report
por: Quental, Carolina, et al.
Publicado: (2023)

Local hyperhemia to heating is impaired in secondary Raynaud's phenomenon
por: Boignard, Aude, et al.
Publicado: (2005)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Myeloproliferative Disease: An Unusual Cause of Raynaud's Phenomenon and Digital Ischaemia
por: Beynon, Celia, et al.
Publicado: (2016)

Raynaud’s phenomenon and the nailfold capillaroscopic findings in a guitar player
por: Sirufo, M M, et al.
Publicado: (2019)

Hypereosinophilic vasculitis with Raynaud phenomenon presentation: a case report
por: Phuong, Duy Le Cao, et al.
Publicado: (2023)

Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report
por: Liu, Lingke, et al.
Publicado: (2023)

Difficulties in diagnosis and treatment of severe secondary Raynaud’s phenomenon in a Cameroonian woman: a case report
por: Agbor, Valirie Ndip, et al.
Publicado: (2016)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon
por: Jacomella, Vincenzo, et al.
Publicado: (2011)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021)

Solvent-Induced Raynaud’s Phenomenon
por: Rodrigues, Helena, et al.
Publicado: (2023)

Early onset of efficacy with erenumab in patients with episodic and chronic migraine
por: Schwedt, Todd, et al.
Publicado: (2018)

Primary Raynaud's phenomenon in an infant: a case report and review of literature
por: Sharathkumar, Anjali A, et al.
Publicado: (2011)

Guillain–Barré syndrome presenting with Raynaud’s phenomenon: a case report
por: Gunatilake, Sonali Sihindi Chapa, et al.
Publicado: (2014)

Deep Vein Thrombosis, Raynaud's Phenomenon, and Prinzmetal Angina in a Patient with Glanzmann Thrombasthenia
por: Nurden, Alan, et al.
Publicado: (2012)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon: A Feasibility Study
por: Ruaro, Barbara, et al.
Publicado: (2019)

Combined Thenar and Hypothenar Hammer Syndromes and Raynaud's Phenomenon Successfully Treated with Iloprost
por: Ciapetti, Alessandro, et al.
Publicado: (2016)

A case of Raynaud's phenomenon of toes induced by whole‐body warm stimulation
por: Akimoto, Takashi, et al.
Publicado: (2021)

Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections
por: Kim, Daniel J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02ca7qj463n48eep2i0h8j990v